GLPwatch
Trials (2167)
Page 8 of 37.
- Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
- Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
- Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
- Imaging in Semaglutide Study
- Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
- Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects
- Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
- A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
- A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
- Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
- Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
- Role of Exenatide in NASH-a Pilot Study
- A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
- Weight Loss and Physical Activity in Overweight/Obese Individuals With Knee Osteoarthritis
- Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents
- Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
- Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
- Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
- LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Exenatide and Brown Adipose Tissue
- Lifestyle Counseling and Medication for Adolescent Weight Management
- Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
- A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
- Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
- A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
- A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
- GLP-1 RA for Stage 1 Type 1 Diabetes
- The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
- Saxenda in Obesity Services (STRIVE Study)
- Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
- Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
- Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
- Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
- Study of Tirzepatide for Recovery and Alcohol Use Management
- Trial for People With Established Type 2 Diabetes During Ramadan
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
- Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
- Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09